4SCAR T for autoimmune diseases
/ SZGIMI
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 30, 2024
GIMI-IRB-24003: Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells
(clinicaltrials.gov)
- P1/2 | N=30 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute
CAR T-Cell Therapy • New P1/2 trial • Immunology
1 to 1
Of
1
Go to page
1